期刊文献+

痛风患者与医师对痛风的认知和诊治现状调查分析 被引量:21

A questionnaire survey of patients and rheumatologists on the awareness of the diagnosis and treat-ment of gout
原文传递
导出
摘要 目的了解我国目前痛风患者对所患痛风的诊疗认知及风湿科医师对痛风的系统化诊治现状,以探讨未来对痛风患者和风湿科医师加强痛风知识教育的侧重点。方法依照痛风患者的关注点和痛风诊疗指南,分别设计痛风患者和风湿科医师问卷,进行面对面调查。124例痛风患者填写了患者问卷;11个省份的269名风湿科医师填写了医师问卷。分别对问卷结果进行统计学分析,统计学方法采用,检验。结果①收回124份患者答卷,8例患者(6.5%)认为急性痛风发作由细菌或病毒引发;7例(5.6%)认为降尿酸目标值为600μmol/L;仍有41例(33.1%)认为秋水仙碱、激素及非甾体抗炎药有降尿酸的作用;②收回252份医师答卷,156名医师(61.9%)认为急性痛风发作时血尿酸水平一定升高;25名(9.9%)认为应在首次痛风急性发作时开始降尿酸治疗;134名(53.2%)认为开始降尿酸治疗时不需要同时服用秋水仙碱预防痛风发作;③根据医师对痛风诊疗指南的认知情况将被调查医师分为2组,调查显示2组医师对急性痛风发作时血尿酸水平的高低、开始降尿酸的时间、降尿酸治疗的目标值、痛风诊断依据、开始治疗是否予秋水仙碱预防复发5个问题的答案的正确选择率差异有统计学意义[分别为56.4%(93/165)与3.4%(3/87),98.2%(162/165)与14.9%(13/87),86.1%(142/165)与6.9%(6/87),70.3%(116/165)与29.9%(26/87),32.7%(54/165)与13.8%(12/87);矿分别为35.745,42.277,48.511,11.673,6.515,P均〈0.05];而患者文化程度及痛风病史长短与痛风诊疗认匀知间差异无统计学意义。结论加强对患者痛风基本知识教育,有助于痛风患者提高对痛风的了解,配合医师做系统治疗;加深风湿病专业医师诊疗培训,有助于进一步加强其对痛风的认识,以求对痛风开展系统化治疗。 Objective To investigate the awareness of gout patients with the diagnosis and treatment of gout and the status of rheumatologists' awareness of the treatment of gout. Methods The questionnaires were developed for gout patients and rheumatologists for the survey of their awareness of gout and its treatment. One hundred and twenty-four cases of gout patients were interviewed and they completed the patients question- naires. Two hundred and sixty-nine rheumatologists in 11 provinces were interviewed and completed the doctors' questionnaire. And the results of questionnaires were analyzed byx2 test. Results One hundred and twenty-four questionnaires of patients were collected. Most patients understood the causes of gout and the target value of uric acid lowering treatment, but they did not realize the related questions about the treatment of gout. Eight patients(6.5%) considered that acute attacks of gout was caused by bacteria or virus; 7 patients (5.6%) thought that the target value of uric acid lowering treatment was 600 uLmol/L. Forty-one patients (33.1%) considered colchicine, steroid and NSAIDs were the uric acid lowering medications. Two hundred and fifty-two questionnaires from rheumatologists were collected. Some rheumatologists did not fully understand the consensus about gout treatment; 156 rheumatologists (61.9%) thought that serum uric acid must be higher during the acute attack stage; 25 physicians (9.9%) thought that the urate lowing drugs should be taken by patients during acute gout attack first time; 134 of them (53.2%) thought that prevention against gout flare using colchicine was not necessary during the first month of urate lowing therapy. According to the cognitionabout the guidelines for diagnosis and t^atment of gout, the surveyed physicians were divided into two groups. And there were significant difference between the two groups about the follow cpestions: the blood uric acid level during acute gnut attacks, the initiation of urate-lowering time, the target value of the urate level, the diagnosis of gout and whether to start colchicine treatment for the prevention of recurrence [56.4%(93/165) vs 3.4%(3/87), 98.2%(162/165) vs 14.9%(13/87), 86.1% (142/165) vs 6.9%(6/87), 70.3% (116/165) vs 29.9%(26/87), 32.7%(54/165 ) vs 13.8%(12/87), respectively; X2=35.745,42.277, 48.511, 11.673, 6.515, all P〈0.05 ]; and the awareness of diagnosis were not statistically different from the treatment of gout. Conclusion The basic knowledge education should be further emphssi~.ed among patients to improve the understanding of gout and to cooperate with doctors to treat gout systematically; and the training should be evolved among rheumatologists to improve the awareness of gout in order to treat gout systematically.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2013年第4期255-258,共4页 Chinese Journal of Rheumatology
关键词 痛风 高尿酸血症 问卷调查 健康教育 Gout Hypemriceraia Questionnaire Health education
  • 相关文献

参考文献10

  • 1Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I : diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIJ). Ann Rheum Dis, 2006, 65: 1301-1311.
  • 2杜蕙,陈顺乐,王元,徐力青.上海市黄浦区社区高尿酸血症与痛风流行病学调查[J].中华风湿病学杂志,1998,2(2):75-78. 被引量:197
  • 3Ogura T, Matsuura K, Matsumoto Y, et al. Recent trends of hyperuricemia and obesity in Japanese male adolescents,1991 through 2002. Metabolism, 2004, 53: 448-453.
  • 4Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part Ⅱ. Arthritis Rheum, 2008, 58: 26-35.
  • 5蒋安,李立平.风湿病学.北京:科学出版社,1998:1468-1469.
  • 6Wesdman KO, Aqudelo CA. Gout basics. Bull Rheum Dis, 2001, 50: 1,3.
  • 7Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol, 2010, 6: 30-38.
  • 8Neoqi T. Clinical practice. Gout. N Engl J Med, 2011, 364: 443-452.
  • 9Borstad GC, Bryant LR, Abel MP, et al. Colchicine for prophy- laxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol, 2004, 31: 2429-2432.
  • 10任立敏,穆荣,刘基凤,黄达奇,栗占国.痛风患者伴发疾病与诊治现状调查[J].中华全科医师杂志,2009,8(10):702-705. 被引量:7

二级参考文献15

  • 1薛如意,姜林娣,于强.门诊风湿病就诊及其影响因素的调查和分析[J].中国临床医学,2005,12(5):866-867. 被引量:3
  • 2张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量:370
  • 3张学顺,于文广,于丽霞,张鲁阳,于瑛.山东省海阳市社区居民高尿酸血症与痛风流行病学调查[J].中华全科医师杂志,2006,5(4):216-219. 被引量:47
  • 4Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum, 1977, 20: 895-900.
  • 5Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol, 2006, 17 : 2937-2944.
  • 6Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics ( ESCISIT ) . Ann Rheum Dis, 2006, 65: 1312-1324.
  • 7Klippel JH, Stone JH, Crofford LJ, et al. Primer on the rheumatic diseases. 13th ed. New york: Springer Science + Business Media, 2007 : 241-249.
  • 8Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med, 2008, 359: 1811-1821.
  • 9Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol , 2007, 18 : 287-292.
  • 10Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension, 2007, 49 : 298-303.

共引文献202

同被引文献129

引证文献21

二级引证文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部